Literature DB >> 15458439

Uric acid and the state of the intrarenal renin-angiotensin system in humans.

Todd S Perlstein1, Olga Gumieniak, Paul N Hopkins, Laine J Murphey, Nancy J Brown, Gordon H Williams, Norman K Hollenberg, Naomi D L Fisher.   

Abstract

BACKGROUND: Experimental hyperuricemia is marked by an activated intrarenal renin-angiotensin system (RAS). The renal vascular response to exogenous angiotensin II (Ang II) provides an indirect measure of intrarenal RAS activity. We tested the hypothesis that the serum uric acid concentration predicts the renal vascular response to Ang II.
METHODS: A total of 249 subjects in high sodium balance had the renal plasma flow (RPF) response to Ang II measured. Para-aminohippuric acid (PAH) clearance was used to estimate RPF. Multivariable regression analysis determined if the serum uric acid concentration independently predicts the RPF response to Ang II. Variables considered included age, gender, race, body mass index (BMI), hypertension status, blood pressure, basal RPF, creatinine clearance, serum insulin, serum glucose, serum high-density lipoprotein (HDL), serum triglycerides, and plasma renin activity (PRA).
RESULTS: Uric acid concentration negatively correlated with the RPF response to Ang II (r=-0.37, P < 0.001). In univariate analysis, age, BMI, hypertension, triglycerides, and blood pressure were negatively associated, and basal RPF, HDL, and female gender were positively associated with the RPF response to Ang II. In multivariable analysis, serum uric acid concentration independently predicted the RPF response to Ang II (beta=-5.3, P < 0.001).
CONCLUSION: Serum uric acid independently predicted blunted renal vascular responsiveness to Ang II, consistent with results from experimental hyperuricemia showing an activated intrarenal RAS. This could be due to a direct effect of uric acid or reflect a more fundamental renal process. These data may have relevance to the association of uric acid with risk for hypertension and nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458439     DOI: 10.1111/j.1523-1755.2004.00909.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  50 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

2.  Higher serum uric acid level increases risk of prehypertension in subjects with normal glucose tolerance, but not pre-diabetes and diabetes.

Authors:  I-H Wu; J-S Wu; Z-J Sun; F-H Lu; C-S Chang; C-J Chang; Y-C Yang
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

3.  Serum Uric Acid Levels and Renal Impairment among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Intervention.

Authors:  Yacov Shacham; Amir Gal-Oz; Nir Flint; Gad Keren; Yaron Arbel
Journal:  Cardiorenal Med       Date:  2016-02-25       Impact factor: 2.041

Review 4.  Novel drugs and intervention strategies for the treatment of chronic kidney disease.

Authors:  Hiddo Jan Lambers Heerspink; Dick de Zeeuw
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

5.  Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial.

Authors:  Yongjun Shi; Wei Chen; Diana Jalal; Zhibin Li; Wenfang Chen; Haiping Mao; Qiongqiong Yang; Richard J Johnson; Xueqing Yu
Journal:  Kidney Blood Press Res       Date:  2011-11-23       Impact factor: 2.687

6.  Is lower uric acid level better? A combined cross-sectional and longitudinal study in the elderly.

Authors:  Chang-Hsun Hsieh; Jiunn-Diann Lin; Chung-Ze Wu; Chun-Hsien Hsu; Dee Pei; Yao-Jen Liang; Yen-Lin Chen
Journal:  Endocrine       Date:  2014-02-21       Impact factor: 3.633

Review 7.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

8.  Serum uric acid is an independent predictor for developing prehypertension: a population-based prospective cohort study.

Authors:  L Liu; Y Gu; C Li; Q Zhang; G Meng; H Wu; H Du; H Shi; Y Xia; X Guo; X Liu; X Bao; Q Su; L Fang; F Yu; H Yang; B Yu; S Sun; X Wang; M Zhou; Q Jia; Q Guo; K Song; G Huang; G Wang; K Niu
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

9.  High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Authors:  Elizabeth T Rosolowsky; Linda H Ficociello; Nicholas J Maselli; Monika A Niewczas; Amanda L Binns; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

10.  Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

Authors:  Laura G Sánchez-Lozada; Virgilia Soto; Edilia Tapia; Carmen Avila-Casado; Yuri Y Sautin; Takahiko Nakagawa; Martha Franco; Bernardo Rodríguez-Iturbe; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.